Aakaar Medical Technologies IPO Sales, Profits, and other Financial Details - What you should know about the Aakaar Medical Technologies IPO

Aakaar Medical Technologies IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Financial Information of Aakaar Medical Technologies Limited IPO
The Revenues from operations for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 6,176.07 Lakh, ₹ 4,627.04 Lakh and ₹ 3,287.85 Lakh. The EBITDA for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 991.48 Lakh, ₹ 515.83 Lakh and ₹ 362.25 Lakh. The Profit after Tax for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 603.95 Lakh, ₹ 287.02 Lakh and ₹ 215.32 Lakh respectively. This indicates a steady growth in financial performance.

Aakaar Medical Technologies Limited Financial Information (Restated Consolidated)

Amount in (₹ in Lakh)

Period Ended	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Reserve of Surplus	1,278.04	1,184.16	896.07
Total Assets	5,410.44	3,400.89	2,322.87
Total Borrowings	2,368.34	1,588.69	653.66
Fixed Assets	22.81	27.13	35.52
Cash	555.08	29.97	18.92
Net Borrowing	1,813.26	1,558.72	634.74
Revenue	6,176.07	4,627.04	3,287.85
EBITDA	991.48	515.83	362.25
PAT	603.95	287.02	215.32
EPS	6.13	3.14	236

Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue, given in RHP.